Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-01
2008-01-01
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S325000, C514S423000, C514S656000, C544S155000, C546S204000, C548S128000, C548S525000, C564S162000
Reexamination Certificate
active
11103958
ABSTRACT:
The present invention provides compounds of the structure:wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases therewith.
REFERENCES:
patent: 4066686 (1978-01-01), Lafon
patent: 4177290 (1979-12-01), Lafon
patent: 4744812 (1988-05-01), Parg et al.
patent: 4927855 (1990-05-01), Lafon
patent: 4935240 (1990-06-01), Nakai et al.
patent: 4980372 (1990-12-01), Nakai et al.
patent: 5180745 (1993-01-01), Lafon
patent: 5391576 (1995-02-01), Lafon
patent: 5401776 (1995-03-01), Laurent
patent: 5563169 (1996-10-01), Yoshida et al.
patent: 5612379 (1997-03-01), Laurent
patent: 5719168 (1998-02-01), Laurent
patent: 6346548 (2002-02-01), Miller et al.
patent: 6455588 (2002-09-01), Scammell et al.
patent: 6472414 (2002-10-01), Biller et al.
patent: 6488164 (2002-12-01), Miller et al.
patent: 6492396 (2002-12-01), Bacon et al.
patent: 6566404 (2003-05-01), Esteve et al.
patent: 6670358 (2003-12-01), Bacon et al.
patent: 6919367 (2005-07-01), Bacon et al.
patent: 6924314 (2005-08-01), Sharma et al.
patent: 7041695 (2006-05-01), Cole
patent: 7119214 (2006-10-01), Lesur et al.
patent: 2002/0045629 (2002-04-01), Bacon et al.
patent: 2 271 112 (1994-06-01), None
patent: WO95/01171 (1995-01-01), None
patent: WO 01/87830 (2001-11-01), None
patent: WO 02/10125 (2002-02-01), None
patent: WO 03/037853 (2003-05-01), None
Annis et al., Peptides-Frontiers of Peptide Science: Proceedings of the Fifteenth American Peptide Symposium, Kluwer Academic Publishers, The Netherlands, 1999 pp. 343-344.
Bordwell et al., Journal of Physical Organic Chemistry, vol. 1, 1988, pp. 225-241.
Edgar et al., The Journal of Pharmacology and Expermental Therapeutics, vol. 283 No. 2, pp. 757-769. (1997).
El-Sakka et al., Arch. Pharm., 327, 1994, pp. 133-135.
Han et al., Journal of Organic Chemistry, 62, 1997 pp. 3841-3848.
Panckeri et al., Sleep, 19(8), pp. 626-631. (1996).
Shelton et al., Sleep, 18(10), pp. 817-826. (1995).
Touret et al., Neuroscience Letters, 189, 1995, pp. 43-46.
Dostert P. and Jalfre M.,Eur. J. Med. Chem., 1974, 9(3), 259-262.
Saenz R. V. and Sowell J. W.,J. Pharm. Sci., 1972, 61(6), 978-980.
Portevin, B. et al.,J. Med. Chem., 1996, 39, 2379-2391.
Bacon Edward R.
Chatterjee Sankar
Dunn Derek
Gruner John A.
Tripathy Rabindranath
Cephalon Inc.
Freistein Andrew B.
Saeed Kamal A.
LandOfFree
Tricyclic aromatic and bis-phenyl sulfinyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic aromatic and bis-phenyl sulfinyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic aromatic and bis-phenyl sulfinyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3953906